title: Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany. rabab.debs@psl.aphp.fr.
authors.forename: Rabab
authors.initials: R
authors.lastname: Debs
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Maillart
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Robert
authors.initials: R
authors.lastname: Fahed
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Caroline
authors.initials: C
authors.lastname: Papeix
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Charles
authors.initials: C
authors.lastname: Duyckaerts
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Christine
authors.initials: C
authors.lastname: Stadelmann
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Damien
authors.initials: D
authors.lastname: Galanaud
authors.affiliation: From the Department of Neurology (R.D., E.M., R.F., C.P., C.L.), Department of Neuroradiology (D.G.), Department of Neuropathology (C.D.), Salpêtrière Hospital, Paris AP HP, France; and Institute of Neuropathology (C.S.), University Medical Center Göttingen, Germany.
authors.forename: Catherine
authors.initials: C
authors.lastname: Lubetzki
mesh_terms: D000328:Adult; D000906:Antibodies / Q000276:immunology*; D001921:Brain / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D000069442:Natalizumab / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D000906:Antibodies; D007155:Immunologic Factors; D000069442:Natalizumab